Embody vs Sprout Health: Which GLP-1 Provider Is Better?
A side-by-side comparison of Embody and Sprout Health covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#21 of 31Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodySprout Health
#2 of 31Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.
Visit Sprout Health| Feature | Embody | Sprout Health |
|---|---|---|
| Our Score | 7.8/10 | 8.8/10 |
| Starting Price | $149/mo | $250/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Users looking for a reliable mid-range option with proven conversion |
| Ranking | #21 | #2 |
Pros & Cons Compared
Embody
Pros
- +24/7 specialist support
- +Competitive pricing
- +Good for beginners
- +Responsive team
Cons
- −Compounded only
- −No insurance
Sprout Health
Pros
- +Operating since 2022 with a consistent track record — no sudden pricing changes or service disruptions
- +Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
- +Dedicated care coordinator assigned to each patient — not a rotating pool of providers
- +Transparent pricing: $250/mo covers medication, shipping, and all consultations
Cons
- −$250/mo puts it in the upper-mid range — $90 more than Willow for a similar all-inclusive model
- −No insurance accepted, and no superbill provided for FSA/HSA reimbursement
Our Verdict
Sprout Health edges out Embody with a score of 8.8/10 vs 7.8/10. If budget is your priority, Embody starts at $149/mo compared to Sprout Health's $250/mo. Sprout Health offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Sprout Health if you want: users looking for a reliable mid-range option with proven conversion.